AelisFarma

The best
knowledge
in our field

AelisFarma

An international network
of partners

  • Neurocentre Magendie, INSERM, University of Bordeaux (France)

Aelis Farma first established its research and development on an exclusive collaboration with the Neurocentre Magendie  in Bordeaux,  one of the most respected and highly innovative Neuroscience Research centers in Europe with extensive experience in the CB1 receptor.

Recently, Aelis Farma extended its portfolio of international collaborations :

 

  • Universitat Pompeu Fabra (Barcelona, Spain)
    – Dr Rafael Maldonado
  • Columbia University (NY, USA)
    – Dr Margaret Haney
  • University of North Carolina Greensboro (USA)
    –Dr Patricia Reggio
  • University of Toronto (Canada)
    – Dr Ruth Ross
  • University of Aberdeen (Scotland, UK)
    – Dr Iain Greig

 

These extremely prestigious laboratories are complementary to Magendie for developing new signaling biased drugs. Thanks to this strategy, Aelis Farma has secured the most knowledge and expertise in the field of signaling specific drugs for the CB1 receptor and other similar GPCRs.

Logo01

 

Investors and
financial partners

Aelis Farma was founded by Dr. Piazza and colleagues with an initial capital of 200 K€. The share capital was rapidly opened to VCs with a 1.000 K€ subscription by Inserm Transfer Initiative (ITI) as lead investor, and an additional 300 K€ was brought in by twin regional funds (ACI and Aqui Invest). Half of the capital of the lead investor ITI is held by major pharmaceutical companies, such as Sanofi Aventis and Pfizer which actively participate in ITI’s board of directors.

Aelis Farma has been granted from the regional government and associated state agencies (BPI France), 2.4 M€ of non-dilutive funds.

In collaboration with Columbia University, it has recently been granted a 3.3 MUSD financing from  NIDA (National Institute on Drug Abuse)  in order to finance  the first  clinical studies for its lead compound AEF0117 in the treatment of cannabis abuse. To comply with specific NIH requirements, Aelis Farma has set up an FCOI (Financial Conflicts of Interest) policy which can be provided upon request at the following address: contact@aelisfarma.com.

fcoi-policy-aelis-farma

 

LogoFinancierShort

 

This internet site is co-financed by the European Union and the Aquitaine Region.
L’Europe s’engage en Aquitaine avec les Fonds Européens de Développement Régional.

 

 

 

The best
knowledge
in our field

AelisFarma